LATEST WEBINARS
Live event: Tuesday 22 August 2017 at 07:00 [PDT] 10:00 [EDT] 15:00 [BST]
All biological protein drugs are immunogenic, which may lead to severe clinical consequences. This makes knowledge of the scientific and regulatory aspects of immunogenicity a must for every drug manufacturer.
Bioanalysis Zone and the University of Wisconsin-Madison’s School of Pharmacy are delighted to present a collection of informative webinars on the latest hot topic areas for the bioanalytical community.
Available to view on demand: In this webinar Wayland Rushing outlines the common pitfalls that result in method transfer failures and how best to avoid them.
Available to view on demand: In this webinar, Adam Hill discusses the changes and challenges in early drug discovery, including new and more efficient discovery strategies.
Available to view on demand: In this webinar, Mattias Trost discusses High-throughput MALDI-TOF mass spectrometry for drug discovery in the ubiquitin system.
Available to view on demand: In this webinar Melanie Leveridge talks about the advancements in MALDI-TOF Mass Spectrometry towards Ultra High Throughput Screening.
Available to view on demand: In this webinar, Harley Wilcox outlines the eccentricity of method validation related to guidance and best practices, including a list of the most useful sources for validation reference.
Live event: Thursday 7 September 2017, 11:00 AM [CT]. In this webinar, Glenn Petrie discusses best practice in optimizing the Chemistry, Manufacturing and Control (CMC) process.
Available to view on demand: In this webinar, Jim Schmidt talks about the 10 things you should know before contracting custom synthesis.
Live event: Thursday 10 August 2017, 11:00 AM [CT]. In this webinar, Glenn Petrie discusses the key to rapid investigational new drug submission and approval in ADC developlment.
Live event: Thursday 21 September 2017, 10:00 AM [CT]. In this webinar, Kenneth Brouwer outlines the initiating events and the hepatocyte’s response in the regulation of bile acids.
Live event: Thursday 14 September 2017, 10:00 AM [CT]: In this webinar Kyunghee Yang and Kim Brouwer outline the species differences in the hepatobiliary disposition and regulation of bile acids.
Latest News
Findings, published in The Lancet, Diabetes & Endocrinology, record the results from a large collaborative meta-analysis of international prospective cohorts.…
Researchers have identified a panel of biomarkers in serum samples that could accurately detect the early stages of pancreatic cancer.
Researchers have developed a diagnostic sensor, using a new heterogenous catalyst 16-sensor array system, that could detect disease with high specificity and sensitivity by analyzing exhaled breath.
Latest Features
Bioanalysis Zone are delighted to partner with The Chromatographic Society at the 22nd International Reid Bioanalytical Forum (4–7 September; Cambourne, UK). We have the pleasure of publishing exclusive content and presentations directly from Reid, including a live stream from the first talk, ‘Bioanalysis of the future’.
In this article, Eric Tewalt and James Gorman discuss updates and considerations for the utilization of hybridization ELISA methods, including associated benefits and challenges, for the bioanalysis of oligonucleotides.
We interviewed Joe Rajarao, Client Engagement Manager at IDBS, who discusses how the use of technology, specifically software, can impact the bioanalytical field.
Automation
Novel inertial microfluidic device could enhance sorting and purification of cells
Automation in Chinese bioanalytical CROs for sustained competitiveness and growth
Chromatography
Researchers identify candidate biomarkers for onset of osteoporosis
Could metabolomic profiling lead to earlier diagnosis of H1N1 influenza pneumonia?
Clinical
Could a blood test detect the risk of cardiovascular disease in asymptomatic patients with lupus?
Could eosinophils be biomarkers for chronic obstructive pulmonary disease?
Collaborations and Mergers
PerkinElmer increases diagnostic capacities with acquisition of EUROIMMUN for $1.3 billion
Charles River partners with OcellO to expand oncology business
Data Processing / Interpretation
Immunosensor developed for biotin detection
Drug Discovery and Development
Recent aspects and challenges in the assessment of immunogenicity
BIOCAD’s rituximab biosimilar receives recommendation for approval in India
‘Heart-on-a-chip’ engineered by Lawrence Livermore researchers
Forensic
Forensic scientists develop a new technique to distinguish the origins of bodily fluids
Disease pathogens rapidly detected by new test
Fingerprints: biological samples for identification of sex and, potentially, more
Imaging
Could chemiluminescence detect cancer?
Lung cancer recurrence detected earlier by circulating tumor cell test
Brain tumor progression and response to treatment tracked by new imaging biomarker
Ligand-binding
Mass Spectrometry
Insulin bioanalysis workflows simplified by new ready-to-use mass spectromic kit
Researchers identify candidate biomarkers for onset of osteoporosis
Other
Poster presentations from the 11th Workshop on Recent Issues in Bioanalysis (WRIB)
BioPharmaSpec announce new in-house analytical services
TRUE-AHF is latest CRO-led international clinical trial reported to lack integrity
Regulated Bioanalysis
Study shows similarity in efficacy and safety between trastuzumab and its biosimilar candidate
FDA approval for first cancer treatment targeting solid tumors based on genetic characteristics
Pfizer’s proposed biosimilar secures approval from FDA advisory committee
Sample preparation, extraction & collection
Sports Drug Testing
Microsampling in sports drug testing – an interview with Laura Mercolini (University of Bologna)
Q&A With Monica Mazzarino & Franscisco Radler on key anti-doping issues
Toxicology
Bioanalysis and toxicology challenges with ADC: how are they different and new?